Results 31 to 40 of about 201,951 (357)

Chronic administration of Glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice [PDF]

open access: yes, 2015
Some anti-diabetic therapies can have adverse effects on bone health and increase fracture risk. In this study, we tested the skeletal effects of chronic administration of two Glucagon-like peptide-1 receptor agonists (GLP-1RA), increasingly used for ...
Al-Jazzar, A   +9 more
core   +2 more sources

Methods for evaluation of early bone healing at titanium implants [PDF]

open access: yes, 2007
Titanium has for a long time been the implant material of choice when in need for abilities as strength, biocompatibility and stability. Although numbers of studies have been made, little is known about the early events in implant healing.
Hederstierna, Karin
core   +1 more source

Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats

open access: yesBMC Musculoskeletal Disorders, 2002
Background Avascular necrosis of bone (osteonecrosis) can cause structural failure and subsequent deformation, leading to joint dysfunction and pain. Structural failure is the result of resorption of necrotic bone during revascularization, before new ...
Aspenberg Per, Åstrand Jörgen
doaj   +1 more source

Modelling the anabolic response of bone using a cell population model [PDF]

open access: yesJ Theor Biol 307 (2012) 42-52, 2011
To maintain bone mass during bone remodelling, coupling is required between bone resorption and bone formation. This coordination is achieved by a network of autocrine and paracrine signalling molecules between cells of the osteoclast lineage and cells of the osteoblastic lineage.
arxiv   +1 more source

ELMO1 Regulates RANKL-Stimulated Differentiation and Bone Resorption of Osteoclasts

open access: yesFrontiers in Cell and Developmental Biology, 2021
Bone homeostasis is a metabolic balance between the new bone formation by osteoblasts and old bone resorption by osteoclasts. Excessive osteoclastic bone resorption results in low bone mass, which is the major cause of bone diseases such as rheumatoid ...
Xinyue Liang   +7 more
doaj   +1 more source

Bone matrix components activate the NLRP3 inflammasome and promote osteoclast differentiation [PDF]

open access: yes, 2017
The NLRP3 inflammasome senses a variety of signals referred to as danger associated molecular patterns (DAMPs), including those triggered by crystalline particulates or degradation products of extracellular matrix. Since some DAMPs confer tissue-specific
Abu-Amer, Yousef   +9 more
core   +2 more sources

The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1 [PDF]

open access: yes, 2020
Pathophysiological bone resorption is commonly associated with periodontal disease and involves the excessive resorption of bone matrix by activated osteoclasts.
Hirai, Kimito   +15 more
core   +1 more source

Resorption controls bone anabolism driven by PTH receptor signaling in osteocytes [PDF]

open access: yes, 2013
The contribution of remodeling-based bone formation coupled to osteoclast activity versus modeling-based bone formation that occurs independently of resorption, to the anabolic effect of PTH remains unclear.
Allen, Matthew R.   +7 more
core   +1 more source

Factors associated with implant marginal bone resorption after implant restoration in elderly patients with severe periodontitis [PDF]

open access: yesXin yixue
Objective To analyze the factors related to implant marginal bone resorption after implant restoration in elderly patients with severe periodontitis. Methods One hundred and ninety-five elderly patients with severe periodontitis who underwent implant ...
LI Yue, MA Yanru
doaj   +1 more source

Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts [PDF]

open access: yes, 2019
Despite recent progress in its treatment, Multiple Myeloma (MM) remains incurable and its associated bone disease persists even after complete remission.
Atkinson, Emily G.   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy